Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 4/20 | 0.46 |
| ▸ | CASP2 | P42575 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25837121 | 0.89 | CYP3A4 (0.43) | DNM1 | |
| SCHEMBL25817012 | 0.86 | SMN1; SMN2 (0.42) | CASP2 | |
| SCHEMBL25837045 | 0.86 | DNM1 (0.56) | DNM1FAAHCASP2NAAAEPHX2 | |
| SCHEMBL25817163 | 0.83 | MEN1 (0.35) | — | |
| SCHEMBL3427647 | 0.78 | SPHK1 (0.54) | CASP2NAAA | |
| SCHEMBL19540784 | 0.76 | CASP2 (0.59) | DNM1FAAHCASP2NAAA | |
| SCHEMBL14577303 | 0.74 | FAAH (0.74) | DNM1FAAHCASP2NAAAEPHX2 | |
| SCHEMBL14576787 | 0.73 | FAAH (0.78) | DNM1FAAHCASP2NAAAEPHX2 | |
| SCHEMBL14577397 | 0.73 | FAAH (0.78) | DNM1FAAHCASP2NAAAEPHX2 | |
| SCHEMBL14577236 | 0.73 | FAAH (0.78) | DNM1FAAHCASP2NAAAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023125806-A1 | CONJUGATE FOR PREVENTING AND TREATING VIRAL INFECTIONS AND USE THEREOF | 苏州爱科百发生物医药技术有限公司 | 2023-07-06 | — | — | WO | disclosed |